TABLE 2.
RV-specific antibodies in stool and plasma of children on enrollmenta
| Study group | Titer of RV-specific IgA in:
|
Titer of RV-specific IgG in plasma | |
|---|---|---|---|
| Stool | Plasma | ||
| Uninfected children | 406 (329–845) (n = 12) | 1,048 (229–1,546) (n = 11) | 25,954 (5,041–41,199) (n = 9) |
| Children with AD | 690 (171–1,442) (n = 19) | 461 (222–670) (n = 19) | 265 (143–683) (n = 18) |
| Children who developed PD | 130 (59–401) (n = 10) | 213 (77–520) (n = 9) | 840 (153–5,249) (n = 9) |
a
Values are medians (25th to 75th quartiles). There were no significant differences in RV-specific IgA titers among the three groups. Significant differences in RV-specific IgG titers in plasma among the three groups were as follows. For the control versus the AD and PD groups, P = 0.002. For the control versus the AD group, P < 0.001. For the control versus the PD group, P = 0.024. The Kruskal-Wallis test was used for comparisons among all three groups; the Mann-Whitney U test was used for comparisons between two groups.